Does Rallies show Form 4 insider transactions for KRMD?

Yes. Rallies tracks KRMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is KRMD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KRMD. It does not provide personalized investment advice.

KRMD (KORU Medical Systems, Inc. Common Stock (DE)) Stock Analysis - Insider Trades

KORU Medical Systems, Inc. Common Stock (DE) (KRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, KRMD trades at $4.00 with a market cap of $175.92M and a P/E ratio of -80.40. KRMD moved +1.14% today. Year to date, KRMD is -28.19%; over the trailing twelve months it is +35.59%. Its 52-week range spans $1.86 to $6.61. Analyst consensus is strong buy with an average price target of $6.75. Rallies surfaces KRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading KRMD stock inside the company?

Recent KRMD insider activity includes Schiller Eric bought 5.00K, Tharby Linda M bought 1.19K, Tharby Linda M bought 1.19K, Pazdan Christopher bought 5.00K, and Adams Thomas Edward bought 5.04K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

KRMD Key Metrics

Key financial metrics for KRMD
Metric	Value
Price	$4.00
Market Cap	$175.92M
P/E Ratio	-80.40
EPS	$-0.05
Dividend Yield	0.00%
52-Week High	$6.61
52-Week Low	$1.86
Volume	410
Avg Volume	0
Revenue (TTM)	$43.26M
Net Income	$-2.28M
Gross Margin	61.93%

Recent KRMD Insider Trades

Schiller Eric bought 5.00K (~$19.56K) on May 18, 2026.
Tharby Linda M bought 1.19K (~$4.67K) on May 15, 2026.
Tharby Linda M bought 1.19K (~$1.42M) on May 15, 2026.
Pazdan Christopher bought 5.00K (~$19.40K) on May 14, 2026.
Adams Thomas Edward bought 5.04K (~$19.46K) on May 14, 2026.

Latest KRMD News

KORU Medical Posts 22% Revenue Growth to $41.1M, International Sales +71% — Mar 13, 2026
KORU Medical Secures FDA 510(k) Clearance for RYSTIGGO Delivery, Sees $10.9M Q4 Revenue — Feb 11, 2026

KRMD Analyst Consensus

5 analysts cover KRMD: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.75.

Common questions about KRMD

Who is trading KRMD stock inside the company?: Recent KRMD insider activity includes Schiller Eric bought 5.00K, Tharby Linda M bought 1.19K, Tharby Linda M bought 1.19K, Pazdan Christopher bought 5.00K, and Adams Thomas Edward bought 5.04K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for KRMD?: Yes. Rallies tracks KRMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is KRMD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KRMD. It does not provide personalized investment advice.